Literature DB >> 4922028

Allotypic suppression of adult mouse spleen cells.

H R Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4922028      PMCID： PMC1455615     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  16 in total

1.  An effect upon the regulation of gene expression: allotype suppression at the a locus in heterozygous offspring of immunized rabbits.

Authors:  R Mage; G O Young; S Dray
Journal:  J Immunol       Date:  1967-03       Impact factor: 5.422

2.  The feed-back mechanism in immunoglobulin synthesis.

Authors:  S Dubiski; K Fradette
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

3.  Suppression of synthesis of allotypically defined immunoglobulins and compensation by another sub-class of immunoglobulin.

Authors:  S Dubiski
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

4.  Antibody production studied by means of the localized haemolysis in gel (LHG) assay. II. Assay procedure.

Authors:  H H Wortis; R B Taylor; D W Dresser
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

5.  Congenic mouse strains with different immunoglobulin allotypes. I. Breeding scheme, histocompatibility tests, and kinetics of gamma G2a-globulin production by transferred cells for C3H.SW and its congenic partner CWB/5.

Authors:  J Klein; L A Herzenberg
Journal:  Transplantation       Date:  1967-11       Impact factor: 4.939

6.  Persistent altered phenotypic expression of allelic gamma-G-immunoglobulin allotypes in heterozygous rabbits exposed to isoantibodies in fetal and neonatal life.

Authors:  R Mage; S Dray
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

7.  Antibody production studied by means of the LHG assay. I. The splenic response of CBA mice to sheep erythrocytes.

Authors:  H H Wortis; R B Taylor; D W Dresser
Journal:  Immunology       Date:  1966-12       Impact factor: 7.397

8.  Studies on rabbit lymphocytes in vitro. 8. The relationship between heterozygosity and homozygosity of lymphocyte donor and per cent blast transformation induced by antiallotype sera.

Authors:  S Sell
Journal:  J Exp Med       Date:  1968-06-01       Impact factor: 14.307

9.  Immunoglobulin synthesis in mice: suppression by anti-allotype antibody.

Authors:  L A Herzenberg; R C Goodlin; E C Rivera
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

10.  Immunoglobulin isoantigens (allotypes) in the mouse. II. Allotypic analysis of three gammaG2-myeloma proteins from (NZB x BALB/c)F1 hybrids and of normal gammaG2-globulins.

Authors:  N L Warner; L A Herzenberg; G Goldstein
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307
View more
  5 in total

1.  Conditions for the development of IgM- and IgG-antibody-secreting cells from primed mouse splenocytes in vitro.

Authors:  R M Maizels; D W Dresser
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

2.  The relationship between the immunoglobulin class of B-cell precursors and the degree of synergism obtained from the presence of T cells.

Authors:  H R Anderson; D W Dresser; H H Wortis
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

3.  Allotype suppression in an adoptive transfer system in adult mice: the specificity and feedback effects of a monoclonal IgG3 anti-(Igh-1b) allotype antibody.

Authors:  E M Curling; D W Dresser
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

4.  Allotype suppression of the responsiveness of adoptively transferred adult spleen cells induced by affinity prepared anti-allotype antibody.

Authors:  S K Lee; D W Dresser
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

5.  Active suppression of immunoglobulin allotype synthesis. I. Chronic suppression after perinatal exposure to maternal antibody to paternal allotype in (SJL x BALB-c)F 1 mice.

Authors:  E B Jacobson; L A Herzenberg
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.